Seasoned private markets executive with multidisciplinary background in corporate finance, operations and strategic portfolio management. Leslie Childs brings experience leading growth equity and operational improvement initiatives across technology and healthcare companies. They have worked with sponsor-backed management teams on revenue scaling, capital raising and exit preparation, and sit on operating committees and advisory boards. Market-facing strengths include deal sourcing, diligence, and value-creation planning for mid-market buyouts and growth investments.
Seasoned private markets executive with multidisciplinary background in corporate finance, operations and strategic portfolio management. Leslie Childs brings experience leading growth equity and operational improvement initiatives across technology and healthcare companies. They have worked with sponsor-backed management teams on revenue scaling, capital raising and exit preparation, and sit on operating committees and advisory boards. Market-facing strengths include deal sourcing, diligence, and value-creation planning for mid-market buyouts and growth investments.
Combines disciplined growth-equity investing with operationally-driven value creation, targeting mid-market technology and healthcare companies where revenue scaling and margin improvement are achievable. Prefers sponsor-backed situations and minority or control growth rounds with 3–7 year horizons, deploying capital alongside management while prioritizing rigorous diligence, milestone-based capital pacing and active board-level involvement. Risk management emphasizes concentrated, thesis-driven bets, operational KPIs for value realization, and clear exit pathways via strategic sale or secondary sponsor recapitalization.
Combines disciplined growth-equity investing with operationally-driven value creation, targeting mid-market technology and healthcare companies where revenue scaling and margin improvement are achievable. Prefers sponsor-backed situations and minority or control growth rounds with 3–7 year horizons, deploying capital alongside management while prioritizing rigorous diligence, milestone-based capital pacing and active board-level involvement. Risk management emphasizes concentrated, thesis-driven bets, operational KPIs for value realization, and clear exit pathways via strategic sale or secondary sponsor recapitalization.
| Trades 2143 | Longs Won 1384/2143 64% | Profit Factor 8.83 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $337,172.84 |
| Average Win $48,998.76 | Best Trade (Oct 15) $10.09M | Sharpe Ratio -11.26 |
| Average Loss -$10,119.72 | Worst Trade (Oct 15) -$988,259.63 | Z-Score 11.58 (100%) |
| Commissions $0 | Avg. Trade Length 1y 10m 1w 5d | Expectancy $28,060.39 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 26,316 | 23,684 | 21,053 | 18,421 | 15,789 | 13,158 | 10,526 | 7,895 | 5,263 | 2,632 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AADR Advisorshares Dorsey Wright ADR ETF | 130 | $10,675 | $10,500.1 | - | -$174.9 | -1.64% | +0.104% |
AAPL Apple Inc. | 16,822 | $2.19M | $5.79M | - | $3.6M | 164.62% | +0.655% |
AAXJ iShares MSCI All Country Asia ex Japan ETF | 200 | $13,136.33 | $21,757 | - | $8,620.67 | 65.62% | -1.427% |
ABBV AbbVie Inc. | 547 | $88,262.63 | $155,369.88 | - | $67,107.25 | 76.03% | +0.226% |
ABNB Airbnb, Inc. | 33 | $2,822 | $5,753.88 | - | $2,931.88 | 103.89% | +0.046% |
ABT Abbott Laboratories | 15,119 | $1.66M | $1.58M | - | -$79,078.63 | -4.76% | -0.119% |
ADM Archer-Daniels-Midland Co | 158 | $14,577.69 | $13,139.28 | - | -$1,438.41 | -9.87% | +0.277% |
ADP Automatic Data Processing Inc. | 7,764 | $1.85M | $2.22M | - | $369,750.37 | 19.93% | +0.312% |
AEP American Electric Power Company, Inc. | 36 | $3,403.36 | $4,559.58 | - | $1,156.22 | 33.97% | +1.903% |
AFL Aflac Inc. | 715 | $52,697.09 | $84,995.62 | - | $32,298.53 | 61.29% | +0.699% |
AIPO Defiance AI & Power Infrastructure ETF | 370 | $12,362 | $9,673.65 | - | -$2,688.35 | -21.75% | -1.563% |
AIRR First Trust RBA American Industrial Renaissance ETF | 100 | $7,998.48 | $9,963 | - | $1,964.52 | 24.56% | -0.777% |
ALC Alcon Inc. | 1,582 | $108,446 | $105,060.62 | - | -$3,385.38 | -3.12% | -0.255% |
AMAT Applied Materials, Inc. | 715 | $71,197.49 | $298,205.05 | - | $227,007.56 | 318.84% | -3.009% |
AMGN Amgen Inc. | 2,928 | $680,117.16 | $1.27M | - | $592,860.12 | 87.17% | +0.168% |
AMT American Tower Corporation | 190 | $40,253 | $35,003.7 | - | -$5,249.3 | -13.04% | +1.582% |
AMZN Amazon.com Inc | 1,407 | $148,548.18 | $356,333.87 | - | $207,785.69 | 139.88% | -0.59% |
APD Air Products and Chemicals, Inc. | 336 | $103,575.43 | $100,042.32 | - | -$3,533.11 | -3.41% | +0.386% |
APO Apollo Global Management, Inc. | 100 | $6,379 | $11,368 | - | $4,989 | 78.21% | +1.618% |
ATI ATI Inc. | 25 | $4,928 | $4,692.62 | - | -$235.38 | -4.78% | -0.848% |